ArticleJID innovations : skin science from molecules to population health2026
Hematological inflammatory markers as predictors of atherosclerotic progression in patients with psoriasis: A retrospective case-control study from the SH-YIMED database.
Article in JID innovations : skin science from molecules to population health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic inflammation drives cardiovascular comorbidity in psoriasis. Clinical-only risk models have limited utility, whereas the predictive value of blood inflammatory markers for psoriatic atherosclerosis is unconfirmed. This hospital-based case-control study enrolled 636 patients with psoriasis who underwent vascular ultrasonography, and 134 matched pairs were obtained through 1:1 propensity score matching. We analyzed primary and exploratory hematological inflammatory markers, examined their links to atherosclerosis using logistic regression and supplementary stratified and nonlinear analyses, and constructed risk prediction models that were assessed by area under the curve, decision curve analysis, net reclassification improvement, and integrated discrimination improvement. Neutrophil-to-lymphocyte ratio (NLR) (OR = 16.33, 95% confidence interval = 7.54-35.35,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.